Indication
Osteomalacia
Osteomalacia is a metabolic bone disorder characterized by the softening of the skeleton due to defective or delayed mineralization of newly formed organic bone matrix (osteoid) in mature, remodeling bone. Read more about Osteomalacia
112 drugs 69 manufacturers
Drugs that treat it
Common Osteomalacia therapies.
ERGOCALCIFEROL (VITAMIN D2)
ERGOCALCIFEROL (VITAMIN D2)
CHOLECALCIFEROL (VITAMIN D3)
ERGOCALCIFEROL (VITAMIN D2)
VITAMIN D2 (ergocalciferol (vitamin D2))
CHOLECALCIFEROL (VITAMIN D3)
VITAJOY DAILY D (cholecalciferol (vitamin D3))
CHOLECALCIFEROL (VITAMIN D3)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonOsteomalacia is a metabolic bone disorder characterized by the softening of the skeleton due to defective or delayed mineralization of newly formed organic bone matrix (osteoid) in mature, remodeling bone.
Primarily affecting adolescents and adults with closed growth plates, it most commonly arises from severe, prolonged vitamin D deficiency, abnormal vitamin D metabolism, or renal phosphate wasting.
The resulting accumulation of unmineralized osteoid impairs structural integrity, clinically presenting as diffuse bone pain, bone tenderness, proximal muscle weakness, a waddling gait, and an increased risk of fragility fractures and pseudofractures (Looser zones).
- nih.gov
Osteomalacia is a metabolic bone disorder characterized by the softening of the skeleton due to defective or delayed mineralization of newly formed organic bone matrix (osteoid) in mature, remodeling bone Primarily affecting adolescents and adults with closed growth plates, it most commonly arises from severe, prolonged vitamin D deficiency, abnormal vitamin D metabolism, or renal phosphate wasting
- orthobullets.com
Osteomalacia is a metabolic bone disorder characterized by the softening of the skeleton due to defective or delayed mineralization of newly formed organic bone matrix (osteoid) in mature, remodeling bone Primarily affecting adolescents and adults with closed growth plates, it most commonly arises from severe, prolonged vitamin D deficiency, abnormal vitamin D metabolism, or renal phosphate wasting The resulting accumulation of unmineralized osteoid impairs structural integrity, clinically prese...
- wikipedia.org
Primarily affecting adolescents and adults with closed growth plates, it most commonly arises from severe, prolonged vitamin D deficiency, abnormal vitamin D metabolism, or renal phosphate wasting
- nih.gov
The resulting accumulation of unmineralized osteoid impairs structural integrity, clinically presenting as diffuse bone pain, bone tenderness, proximal muscle weakness, a waddling gait, and an increased risk of fragility fractures and pseudofractures (Looser zones)
- nih.gov
The resulting accumulation of unmineralized osteoid impairs structural integrity, clinically presenting as diffuse bone pain, bone tenderness, proximal muscle weakness, a waddling gait, and an increased risk of fragility fractures and pseudofractures (Looser zones)
Personalize your experience
Follow Osteomalacia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.